FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
In a Senate hearing, Senator Bernie Sanders pushed Robert F. Kennedy Jr. again on his past support for unsupported claims that vaccines caused autism.
Patients and health care advocates said the abrupt decision to halt U.S. funding for a lifesaving H.I.V. program led to widespread confusion. The backtracking didn’t help.
The company said the unlocking function, part of a pilot program in New York City, will be expanded this year.
The decision will further broaden the use of the blockbuster drug.
PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.
Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing interest. All that’s needed: brave volunteers.
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine.
Plus, a Super Bowl three-peat?
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.